Literature DB >> 1341076

Praomys (Mastomys) natalensis: a model for gastric carcinoid formation.

O Nilsson1, B Wängberg, L Johansson, I M Modlin, H Ahlman.   

Abstract

The gastric carcinoid tumors of Praomys (Mastomys) natalensis have been reviewed with respect to histogenesis, development, biochemistry, and morphological properties. Multicentric gastric carcinoids frequently develop in the oxyntic mucosa of aging Mastomys. The development of these tumors can be significantly enhanced by drug-induced hypergastrinemia, e.g., histamine2-receptor blockade. Spontaneous and drug-induced gastric carcinoids are endocrine in nature, as evidenced by their argyrophilic staining properties and chromogranin A content. They are also rich in histidine decarboxylase activity and produce large amounts of histamine, although other hormones, such as peptide YY and enteroglucagon, have also been demonstrated in these tumors. Ultrastructurally, gastric carcinoids are composed of tumor cells with typical secretory granules resembling those of enterochromaffin-like (ECL) cells. A close examination of the gastric carcinoids in Mastomys reveals striking similarities with gastric carcinoids developing in humans suffering from chronic atrophic gastritis type A or from the Zollinger-Ellison syndrome in combination with multiple endocrine neoplasia type 1 (MEN-1). Both these conditions are associated with hypergastrinemia and a higher risk for developing multi-centric gastric carcinoids of ECL-cell origin. The Mastomys tumor model therefore appears to be a significant experimental model in which induction and formation of gastric carcinoid tumors can be studied.

Entities:  

Mesh:

Year:  1992        PMID: 1341076      PMCID: PMC2589773     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  58 in total

1.  The role of gastric resection in the management of multicentric argyrophil gastric carcinoids.

Authors:  B Wängberg; L Grimelius; G Granérus; N Conradi; S Jansson; H Ahlman
Journal:  Surgery       Date:  1990-11       Impact factor: 3.982

2.  Gastric ECL-cell hyperplasia and carcinoids in rodents following chronic administration of H2-antagonists SK&F 93479 and oxmetidine and omeprazole.

Authors:  G R Betton; C S Dormer; T Wells; P Pert; C A Price; P Buckley
Journal:  Toxicol Pathol       Date:  1988       Impact factor: 1.902

Review 3.  Histopathological classification of nonantral gastric endocrine growths in man.

Authors:  E Solcia; C Bordi; W Creutzfeldt; Y Dayal; A D Dayan; S Falkmer; L Grimelius; N Havu
Journal:  Digestion       Date:  1988       Impact factor: 3.216

Review 4.  The gastroenteropancreatic endocrine system and related tumors.

Authors:  E Solcia; C Capella; R Fiocca; M Cornaggia; F Bosi
Journal:  Gastroenterol Clin North Am       Date:  1989-12       Impact factor: 3.806

5.  Two cases of gastric carcinoids: diagnostic and therapeutic aspects.

Authors:  H Ahlman; A Dahlström; L Enerbäck; G Granérus; O Nilsson; S Persson; L E Tisell
Journal:  World J Surg       Date:  1988-06       Impact factor: 3.352

6.  Characteristics of the spontaneous gastric endocrine tumor of mastomys.

Authors:  I M Modlin; K A Zucker; M J Zdon; J Sussman; T E Adrian
Journal:  J Surg Res       Date:  1988-03       Impact factor: 2.192

Review 7.  Proposed mechanism of induction of gastric carcinoids: the gastrin hypothesis.

Authors:  R Håkanson; F Sundler
Journal:  Eur J Clin Invest       Date:  1990-10       Impact factor: 4.686

Review 8.  Gastric carcinoids and related endocrine growths.

Authors:  E Solcia; C Capella; F Sessa; G Rindi; M Cornaggia; C Riva; L Villani
Journal:  Digestion       Date:  1986       Impact factor: 3.216

9.  Omeprazole and ranitidine, antisecretagogues with different modes of action, are equally effective in causing hyperplasia of enterochromaffin-like cells in rat stomach.

Authors:  B Ryberg; A E Bishop; S R Bloom; E Carlsson; R Håkanson; H Larsson; H Mattsson; J M Polak; F Sundler
Journal:  Regul Pept       Date:  1989-05

10.  Multifocal gastric carcinoid tumours, achlorhydria, and hypergastrinaemia.

Authors:  R F Harvey; M J Bradshaw; C M Davidson; S P Wilkinson; P S Davies
Journal:  Lancet       Date:  1985-04-27       Impact factor: 79.321

View more
  10 in total

1.  Ultrastructure of ECL cells in Mastomys after long-term treatment with H2 receptor antagonist loxtidine.

Authors:  Reidar Alexander Vigen; Mark Kidd; Irvin M Modlin; Duan Chen; Chun-Mei Zhao
Journal:  Med Mol Morphol       Date:  2012-06       Impact factor: 2.309

2.  Observations on relationship between hypergastrinemia, multiple gastric carcinoids, and pancreatic mass.

Authors:  I M Modlin; C J Gilligan; G P Lawton; L H Tang; A B West; R Lindenberg
Journal:  Dig Dis Sci       Date:  1996-01       Impact factor: 3.199

Review 3.  Translational research in neuroendocrine tumors: pitfalls and opportunities.

Authors:  J Capdevila; O Casanovas; R Salazar; D Castellano; A Segura; P Fuster; J Aller; R García-Carbonero; P Jimenez-Fonseca; E Grande; J P Castaño
Journal:  Oncogene       Date:  2016-09-19       Impact factor: 9.867

Review 4.  Gastric cancer: animal studies on the risk of hypoacidity and hypergastrinemia.

Authors:  Reidar Fossmark; Gunnar Qvigstad; Helge-L Waldum
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

5.  Priorities for improving the management of gastroenteropancreatic neuroendocrine tumors.

Authors:  Irvin M Modlin; Steven F Moss; Daniel C Chung; Robert T Jensen; Elizabeth Snyderwine
Journal:  J Natl Cancer Inst       Date:  2008-09-09       Impact factor: 13.506

6.  Care of Mastomys in the laboratory.

Authors:  Jodi Scholz; Steven Wilson
Journal:  Lab Anim (NY)       Date:  2016-05-20       Impact factor: 12.625

Review 7.  Histamine metabolism of gastric carcinoids in Mastomys natalensis.

Authors:  L Kölby; B Wängberg; H Ahlman; I M Modlin; O Nilsson
Journal:  Yale J Biol Med       Date:  1998 May-Aug

Review 8.  Gastroenteropancreatic neuroendocrine neoplasms: genes, therapies and models.

Authors:  Kenta Kawasaki; Masayuki Fujii; Toshiro Sato
Journal:  Dis Model Mech       Date:  2018-02-26       Impact factor: 5.758

Review 9.  Mastomys Species as Model Systems for Infectious Diseases.

Authors:  Daniel Hasche; Frank Rösl
Journal:  Viruses       Date:  2019-02-21       Impact factor: 5.048

10.  Comparative Genomic Characterization of the Multimammate Mouse Mastomys coucha.

Authors:  Aaron Hardin; Kimberly A Nevonen; Walter L Eckalbar; Lucia Carbone; Nadav Ahituv
Journal:  Mol Biol Evol       Date:  2019-12-01       Impact factor: 16.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.